Day: July 17, 2024

Form 8.3 – [MATTIOLI WOODS PLC] – 16 07 2024 – (CGWL)

Written by Customer Service on July 17, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree MATTIOLI WOODS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: MATTIOLI WOODS PLC AS AN ASSOCIATE...

Form 8.3 – [KEYWORDS STUDIOS PLC] – 16 07 2024 – (CGWL)

Written by Customer Service on July 17, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree KEYWORDS STUDIOS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024

Written by Customer Service on July 17, 2024. Posted in Public Companies.

Company AnnouncementNet sales of DARZALEX® in the second quarter of 2024 totaled USD 2,878 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen)COPENHAGEN, Denmark; July 17, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX® (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO® in the U.S.), as reported by Johnson & Johnson were USD 2,878 million in the second quarter of 2024. Net trade sales were USD 1,641 million in the U.S. and USD 1,237 million in the rest of the world. Genmab receives royalties on the worldwide net sales of DARZALEX, both the intravenous and SC products, under the exclusive worldwide license to Janssen to develop, manufacture and commercialize...

Tallinn and Helsinki Ports receive EU funding worth 15,4 million euros

Written by Customer Service on July 17, 2024. Posted in Public Companies.

The TWIN-PORT VI project has received a funding decision from the EU. The four-year project is a continuation of the long-term cooperation between ports of Tallinn and Helsinki, aiming to reduce transport system emissions and to improve conditions for passenger and freight transport operations. AS Tallinna Sadam (hereinafter: Tallinna Sadam) focuses on environmental impacts in the project and plans to build on-shore power systems in Muuga Harbour so that ro-ro and container vessels can use electricity from the shore power grid. The Port of Helsinki aims to develop the Vuosaari Harbour. The total cost of the project covering two harbours is 30.8 million euros, half of which is financed by the European Union. Budget of Tallinna Sadam for the entire project is 20.3 million euros, and about 10.5 million euros is estimated by Helsinki Port....

Empowering Global Expansion for Enterprises, Aurora Mobile Impresses at The MarTech Summit

Written by Customer Service on July 17, 2024. Posted in Public Companies.

SHENZHEN, China, July 17, 2024 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, shines at The MarTech Summit with its cutting-edge products, EngageLab and GOTBots.ai (“GPTBots”). On July 9th, 2024, The MarTech Summit was held at the Shangri-La Hotel in Kowloon, Hong Kong. Aurora Mobile, along with senior-level executives from multinational companies, gathered to explore how MarTech can drive the global business expansion of enterprises. With the general theme “Levelling Up With High-Performance & Sleeker MarTech,” the agenda was packed with engaged panel discussions, fireside chats, and keynote presentations, focusing on data-driven marketing, customer...

iQIYI to Report Second Quarter 2024 Financial Results on August 22, 2024

Written by Customer Service on July 17, 2024. Posted in Public Companies.

BEIJING, July 17, 2024 (GLOBE NEWSWIRE) — iQIYI, Inc. (NASDAQ: IQ) (“iQIYI” or the “Company”), a leading provider of online entertainment video services in China, today announced that it will report its financial results for the second quarter ended June 30, 2024 before the U.S. market opens on August 22, 2024. iQIYI’s management will hold an earnings conference call at 7:00 AM on August 22, 2024, U.S. Eastern Time (7:00 PM on August 22, 2024, Beijing Time). Please register in advance of the conference using the link provided below. Upon registering, you will be provided with participant dial-in numbers, passcode and unique access PIN by a calendar invite. Participant Online Registration: https://s1.c-conf.com/diamondpass/10040374-iu4p0d.html It will automatically direct you to the registration page of “iQIYI...

4DMT Announces Positive Phase 2 PRISM Interim Results for Intravitreal 4D-150 in a Broad Wet AMD Population Affirming Favorable Safety Profile and Robust Clinical Activity

Written by Customer Service on July 17, 2024. Posted in Public Companies.

Robust reduction in anti-VEGF injection treatment burden through Week 24 achieved in 30 patients at planned Phase 3 dose (3E10 vg/eye) with 89% reduction in annualized injection rate; 93% of patients received 0 or 1 injection and 77% were injection-free Improvement in mean best corrected visual acuity (BCVA) from baseline through Week 24 achieved at 3E10 vg/eye dose (+4.2 letters); dose response in favor of 3E10 vg/eye dose demonstrated (+5.7 letters vs low dose) 3E10 vg/eye dose demonstrated sustained and greater anatomic control without fluctuations Favorable safety profile confirmed in 139 patients treated to date with 4D-150 across wet age-related macular degeneration (wet AMD; PRISM trial) and diabetic macular edema (DME; SPECTRA trial) No significant inflammation reported in 51 patients treated to date with 3E10 vg/eye dose and...

Correction: Hexagon Purus ASA: Share capital increase registered

Written by Customer Service on July 17, 2024. Posted in Public Companies.

Correction: Updated with correct number of shares issued Reference is made to the stock exchange announcement by Hexagon Purus ASA on 18 March 2024 regarding the issue of 909,742 new shares entitled to employees in accordance with the long-term incentive plan of December 2020 (the “2020 LTIP”). The share capital increase pertaining to the issuance of the new shares under 2020 LTIP has been registered with the Norwegian Register of Business Enterprises. Hexagon Purus’ new registered share capital is NOK 27,770,719.80 divided into 277,707,198 shares, each with a nominal value of NOK 0.10 per share. For additional information, please contact: Mathias Meidell, IR Director, Hexagon Purus Telephone: +47 909 82 242 | mathias.meidell@hexagonpurus.com About Hexagon Purus ASA Hexagon Purus enables zero emission mobility for a cleaner energy future....

CRCC: Spearheading the Modernization of Port of Spain General Hospital

Written by Customer Service on July 17, 2024. Posted in Public Companies.

BEIJING, July 17, 2024 (GLOBE NEWSWIRE) — Since the successful completion of the Scarborough General Hospital project in Tobago in 2012, China Railway Construction Corporation Limited (CRCC) has been steadily expanding its footprint in the healthcare sector across Latin America. To date, CRCC has delivered nine landmark healthcare facilities in the Republic of Trinidad and Tobago (TRINIDAD AND TOBAGO), each marking a significant milestone in the nation’s medical infrastructure. The current redevelopment of the main building at Port of Spain General Hospital is taking place in Port of Spain, TRINIDAD AND TOBAGO’s capital city. Due to the structural aging and seismic damage sustained by the original building, the government decided to replace the existing structure with a new, modern facility. The new hospital, currently under construction...

PDMR Notification

Written by Customer Service on July 17, 2024. Posted in Public Companies.

THAMES VENTURES VCT 2 PLCLEI: 21380035MV1VRYEXPR95 PDMR NOTIFICATION17 JULY 2024 In accordance with Listing Rule 9.6.14, Thames Ventures VCT 2 plc (the “Company”) announces that Chris Allner has been appointed as a Non-Executive Director of Pembroke VCT plc with effect from 1 June 2024. For further information, please contact: Company SecretaryForesight Group LLPContact: Stephen Thayer Tel: 0203 667 8100 Investor RelationsForesight Group LLPContact: Andrew James Tel: 0203 667 8181

Day: July 17, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals